Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JW Therapeutics
Biotech
2 biotechs pen licensing pact for cell therapy cancer platform
Bluebird spinout 2seventy bio is handing JW Therapeutics a license for its preclinical solid tumor program in certain areas of China.
Gabrielle Masson
Oct 27, 2022 11:00am
JW Therapeutics rakes in $300M Hong Kong IPO
Nov 4, 2020 11:00am
Juno joint venture seeks IPO haul to bring CAR-Ts to China
Aug 17, 2020 8:40am
Juno-WuXi AppTec JV JW Therapeutics nabs $100M for cell therapy
Jun 11, 2020 8:05am
